Open Access

Influence of nanofibers on growth and gene expression of human tendon derived fibroblast

  • Christina Theisen1Email author,
  • Susanne Fuchs-Winkelmann1,
  • Karola Knappstein1,
  • Turgay Efe1,
  • Jan Schmitt1,
  • Juergen RJ Paletta1 and
  • Markus D Schofer1
BioMedical Engineering OnLine20109:9

https://doi.org/10.1186/1475-925X-9-9

Received: 10 September 2009

Accepted: 17 February 2010

Published: 17 February 2010

Abstract

Background

Rotator cuff tears are a common and frequent lesion especially in older patients. The mechanisms of tendon repair are not fully understood. Common therapy options for tendon repair include mini-open or arthroscopic surgery. The use of growth factors in experimental studies is mentioned in the literature. Nanofiber scaffolds, which provide several criteria for the healing process, might be a suitable therapy option for operative treatment. The aim of this study was to explore the effects of nanofiber scaffolds on human tendon derived fibroblasts (TDF's), as well as the gene expression and matrix deposition of these fibroblasts.

Methods

Nanofibers composed of PLLA and PLLA/Col-I were seeded with human tendon derived fibroblasts and cultivated over a period of 22 days under growth-inductive conditions, and analyzed during the course of culture, with respect to gene expression of different extra cellular matrix components such as collagens, bigylcan and decorin. Furthermore, we measured cell densities and proliferation by using fluorescene microscopy.

Results

PLLA nanofibers possessed a growth inhibitory effect on TDF's. Furthermore, no meaningful influence on the gene expression of collagen I, collagen III and decorin could be observed, while the expression of collagen X increased during the course of cultivation. On the other hand, PLLA/Col-I blend nanofibers had no negative influence on the growth of TDF's. Furthermore, blending PLLA nanofibers with collagen had a positive effect on the gene expression of collagen I, III, X and decorin. Here, gene expression indicated that focal adherence kinases might be involved.

Conclusion

This study indicates that the use of nanofibers influence expression of genes associated with the extra cellular matrix formation. The composition of the nanofibers plays a critical role. While PLLA/Col-I blend nanofibers enhance the collagen I and III formation, their expression on PLLA nanofibers was more comparable to controls. However, irrespective of the chemical composition of the fibres, the collagen deposition was altered, an effect which might be associated with a decreased expression of biglycanes.

Background

The rotator cuff is a muscle coat that encloses the shoulder and with its four parts, is responsible for the movement and integrity of the glenohumeral joint. Tears mainly occur in the supraspinatus tendon [1, 2]. In common literature, the frequency of rotator cuff tears in anatomical studies varies between 17% and 72% [3, 4]. The appearance of a rotator cuff lesion is related to and increases with the patient' age [5]. In 1911, E. A. Codman published the first successful rotator cuff refixation after open repair of a supraspinatus tendon using silk sutures [6]. Compared to other injuries, rotator cuff tears show no tendency towards healing, so that operative surgery is necessary in most cases. Rerupture due to, osteoporoses, poor vascularization, degenerative changings such as atrophy and fatty degeneration of the muscle or the size of the original tear contribute to the high failure rate [79]. Because of this, there is strong clinical relevance towards methods which improve rotator cuff tendon healing. It was also shown that rotator cuff healing occurs by reactive scar formation rather than regeneration of a histologically normal insertion zone [10].

Tendons and ligaments are very similar connective tissue. They are an essential component of the musculoskeletal system. They provide stability and movement of joints. The strength of tendons and ligaments varies depending on anatomic request and condition and they are able to adapt to various conditions [11]. There are few specific biochemical markers known for tendons and ligaments [12, 13].

The current literature provides promising results with alternative methods for tendon repair using allogeneic or xenogeneic grafts such as collagen-rich dermis and small intestinal submucosa [1417]. Besides tissue scaffolds the local application of growth factors such as fibroblast growth factor-2 improves the rotator cuff repair and accelerates the initial tendon-to-bone healing [18, 19]. Seeherman et al. showed that delivery of recombinant human bone morphogenetic protein-12 (rhBMP-12) in a collagen or hyaluronan sponge resulted in accelerated healing of acute full-thickness rotator cuff repairs in a sheep model [20].

In further studies, we showed that poly(l-lactic acid) (PLLA) and collagen-I (Col-I) electrospun nanofibers are applicable grafts for the reconstruction of large bony defects by promoting growth and osteogenetic differentiation of stem cells [21, 22]. In this study we focused on the effects of nanofiber scaffolds on human tendon derived fibroblasts (TDF's), gene expression and matrix deposition of these fibroblasts.

Therefore, an ideal scaffold for tendon repair should match several criteria. It has to be tolerated by the tenocytes, it must facilitate the colonialisation (promoting either migration or proliferation of the cells) and furthermore, it must enhance the formation of the extra cellular matrix (ECM) during the healing process. Here, scaffolds based on electrospun nanofibers, offer great advantages. Such matrices show morphological similarities to the natural ECM, characterized by ultrafine continuous fibers, high surface-to-volume ratio, high porosity and variable pore-size distribution [23]. These nanofibers can be produced by a broad spectrum of polymers including biocompatible as well as biodegradable polymers, such as poly(glycolic acid) (PGA), PLLA, poly-ε caprolactone (PCL), polyurethanes, polyphosphazenes, collagen, gelatin, and chitosan as well as copolymers from the corresponding monomers in various compositions [24, 25]. This allows the production of a broad spectrum of nanofiber based scaffolds with different mechanical and biophysical properties. Depending on the polymer the nanofibers were tolerated by a variety of cell types including human mesencymal stem cells (hMSC) and TDF's.

Methods

Construction of nanofibers and characterization

A 4.5% (w/v) PLLA (Resomer L210, Boehringer Ingelheim Germany) solution in hexafluoroisopropanol (HFIP) was prepared at room temperature by stirring overnight until a homogenous solution was obtained. Spinning process was performed at a flow rate of 14 μl/min with an applied voltage of 10 - 18 kV and a distance of 15 cm.

The PLLA collagen-I (PLLA/Col-I) blend nanofibers with a polymer ratio of 4:1 were fabricated as reported earlier [22].

For cell culture experiments, all samples of nonwoven nanofibers were prepared under aseptic conditions and collected on 19 mm cover slips.

Static contact angles of water were measured using the sessile drop method with a G10 Drop Shape Analysis System (Krüss, Hamburg, Germany) and calculated using Data Physics SCA20 Contact Angle Analyzer Software. For scanning electron microscopy (SEM), samples were splutter-coated with gold in an AUTO-306 (BOC Edwards, Crawley, Sussex, U.K.) high-vacuum coating system and examined in a SEM (S-4100, Hitachi Ltd., Tokyo, Japan) at an accelerating voltage of 5 kV in the SE mode.

Human tendon derived fibroblasts: cell isolation and culture

TDF's were obtained from consenting patients with the approval of the institutional review board. The indication for surgery with tenotomy of the long biceps tendon was instability of the tendon, tendonitis or incomplete rupture of the long biceps tendon. The routinely removed tendon was cut into pieces of approximately 5 mm and subjected to collagenase digestion for a period of 30 min at 37°C. After removal of the collagenase, pieces were rinsed with phosphate puffered saline (PBS) and explanted to culture flasks in Dulbecco' modified eagles medium (DMEM) containing 10% fetal calf serum (FCS) and 1% penicillin/streptomycin. Within 1 week - when cells migrated from the tendon and became attached to the culture flask - tendon pieces were removed and the cells were further cultured to confluence.

For experiments, TDF's (passage 2) were seeded at a density of 3 × 104 cells/cm2 on cover slips or cover slips coated with either PLLA or PLLA/Col-I blend nanofibers in growth medium (DMEM), with low glucose and glutamine (PAA, Linz, Austria) supplemented with 10% FCS from selected lots (Stem Cell Technologies, Vancouver, Canada) and 1% penicillin/streptomycin. In order to facilitate the deposition of collagen, 0.05 mM ascorbic acid-2-phosphate was added to the medium. The medium was replaced every second day of culture during the experiments.

Vitality staining

Vitality staining was performed using fluoreszein-diazetat (FDA). After 4 days of incubation, cover slips were removed from culture, rinsed with PBS and stained with FDA at a concentration of 5 μg/mL. Fluorescence microscopy was done using a Leica DM5000. Microphotographs of at least three different areas were made at a primary magnification of 20 fold high power field (HPF). Area of fluorescence was determined using Quips analysis software.

Gene expression analysis

RNA was extracted from cell layers at days 4, 9 and 22 of culture using RNeasy Mini Kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer and quantified spectrometrically. The cDNA was synthesized using Omniscript reverse transcriptase and oligo-dT primer in the presence of dNTP (Qiagen GmbH, Hilden, Germany). Quantitative RT-PCR was performed and monitored using a Mastercycler® ep realplex Detection System (Eppendorf, Hamburg, Germany) and RealMaster Mix CyberGreen (Eppendorf, Hamburg, Germany). Genes of interest were analyzed in cDNA samples (5 μl for a total volume of 25 μl/reaction) using DeltaDeltaCt method and CyberGreen. Primers cycle temperatures and incubation times for collagens I, III and X as well as decorin and biglycan were published by Molloy et al. [26]. Focal adhesion kinase-1 (FAK) was analyzed using forward primer 5'ACC TCA GCT AGT GAC GTA TGG -3' and reverse primer 5'CGG AGT CCC AGG ACA CTG TG 3' (gen bank L0518666). For the protein-tyrosine kinases (PYK) analyzation, the following primers were used: forward 5'CAG CAG TAC GCC TCG CTC AG3' and reverse 5'TCA GCC TCT GCT AGG GAT GAG3' (gen bank U3328466). Phosphoinosytol-3-kinase (PI3K) was measured by using the forward primer 5'CCT GAT CTT CCT CGT GCTG CTC3' and reverse primer 3'ATG CCA ATG GAC AGT GTT CCT CTT5'. Cyclin D 1 (CCND) was analyzed using forward primers 5'ACG AAG GTC TGC GCG TGT T3' and reverse 5'CCG CTG GCC ATG AAC TAC CT3' (UniGene Hs.523852).

Immunofluorescence microscopy of collagen I

Samples obtained at day 22 were fixed in aceton/methanol, washed with PBS (3×), and exposed to blocking buffer (1% donkey serum albumin PBS) for a further 30 min at room temperature in order to minimize non-specific absorption of the antibodies. After another wash in PBS (3×), the cells were incubated with primary antibodies against Col-I (Abcam, Ab6308, Cambridge, United Kingdom).

Visualization was done after washing in PBS (3×) using cy-3-conjugated secondary antibody (Dianova, Hamburg, Germany) at room temperature (1 hour). The slices were stained with DAPI (4.6-diamino-2-phenylindole) and embedded in mounting medium. Fluorescence microscopy was done using a Leica DM5000. Microphotographs of at least three different areas were made at a primary magnification of 20 HPF. Intensity of fluorescence was determined using Quips analysis software. Total cell count of DAPI stained nuclei, were obtained.

Statistics

All values were expressed as mean ± standard error of three different patients analyzed at least in duplicate and compared using students' t-test or ANOVA with Bonferroni as a post hoc test. Values of p < 0.05 were considered to be significant.

Results

Characterisation of nanofiber scaffolds

Scanning electron microscopy PLLA nanofibers revealed a 3-D non-woven network with a mean diameter of 0.754 ± 295 μm. Fibers were smooth in structure (figure 1A), and had a contact angle of 118.4°. In contrast, blending with collagen I resulted in a decrease in fibre diameter (0.238 ± 93 μm) (figure 1B). Furthermore, the fibre scaffolds were more hydrophilic with a contact angle of less then 30°.
Figure 1

Fiber characterization. SEM analysis of PLLA (A) and PLLA/Col-I nanofibers (B).

Influence of PLLA and PLLA/Col-I nanofibers on cell vitality and proliferation

In order to describe the biological effects, we first analyzed the effect of PLLA and PLLA/Col-I blend nanofibers scaffold on the vitality of TDF's. As shown in figure 2, the presence of PLLA/Col-I nanofibers had no effect on cell densities after 4 days of cultivation (p = 1.000). On the other hand, significantly less living cells were detected on PLLA nanofibers at the same time (p = 0.001). This was accompanied by a down regulation of CCND (cyklin1D) gene expression (p = 0.001). CCND promotes progression through the G1-S phase of the cell cycle.
Figure 2

Influence of PLLA and PLLA/Col-I nanofibers on growth of TDF's. Area of FDA positive cells cultured over a period of 4 days (A) and relative CCND expression (B). Immunofluorescence microphotographs of FDA staining of TDF's cultured on glass (C), PLLA (D) and PLLA/Col-I (E) nanofiber scaffolds.

Influence of PLLA and PLLA/Col-I nanofibers on matrix formation of hMSC

Fibroblast production and deposition of type I collagen of TDF's cultured on PLLA and PLLA/Col-I blend nanofiber scaffolds was evaluated using time dependent gene expression analysis after 4, 9 and 22 days of cultivation as well as immunofluorescence analysis after 22 days of culture. As shown in figure 3, the presence of PLLA nanofibers had little effect on the expression of collagen I gene compared to cover slip control. Consequently, immunostaining of collagen I was similar to that obtained on cover slip control. Although there was a broad inter patient variability, the expression of collagen-I increased about 37 times compared to controls when TDF's were cultured in the presence of PLLA/Col-I blend nanofibers (p = 0.009). Although this increase was not stable over time, immunostaining of collagen I was more compact in structure and more intense in fluorescence compared to PLLA scaffolds or cover slip control when analyzed after 22 days.
Figure 3

Influence of PLLA and PLLA/Col-I nanofibers on gene expression Col-I deposition of TDF's. Time course of collagen-I gene expression of TDF's on nanofibers compared to cover slips control (A). Immunofluorescence microphotographs of Col-I (red) deposition after 22 days of culture cover slip control (B), PLLA nanofibers (C) and PLLA/Col-I nanofibers (D).

Although the PLLA nanofibers did not influence the expression of collagen I gene, the presence of PLLA had a notable impact on the deposition of collagen. While TDF's on glass deposited the collagen in fiber bundles, on nanofibers the distribution was more equal (figure 3B-D) and similar to that obtained on PLLA/Col-I blend nanofibers.

Due to the fact that during tendon repair, besides collagen I, the collagens III and X have been reported to play an important role and their gene expression was analyzed in a time dependent manner as well (figure 4). Similar to the gene expression of collagen I, the presence of PLLA nanofibers had only little effect on the collagen III gene expression, while the presence of PLLA/Col-I blend nanofibers resulted in a 5 to 100 fold increase depending on the cells (p = 0.009). Furthermore, this increase was prolonged and detectable over the whole period of culture (p = 0.038, day 9; p = 0.682, day 22).
Figure 4

Influence of PLLA and PLLA/Col-I nanofibers on gene expression Col-I deposition of TDF. Time course of collagen-III (A) and collagen-X (B) gene expression of TDF's cultured on PLLA and PLLA/Col-I nanofibers as compared to cover slips control.

Focusing on the gene expression of collagen X, both the presence of PLLA as well as PLLA/Col-I nanofibers resulted in a stable up regulation of the observed time. However statistical significance was reached only in case of PLLA/Col-I nanofibers at day 4 of cultivation (p = 0.021).

Due to the fact that besides collagen, glucosaminoglycanes play an important role in tendon formation and function, we analyzed the gene expression of decorin and biglycan. As shown in figure 5, gene expression of decorin showed a comparable pattern to the expression of collagen I. Here, the initial increase on PLLA nanofibers was about 2 fold and on PLLA/Col-I nanofibers 4 fold, with statistical significance in case of PLLA/Col-I (p = 0.010). Focusing on the expression of biglycan, different results were obtained. The presence of nanofibers down regulated the gene expression irrespective of the nanofiber polymer composition. Significance was reached only during late time of cultivation (PLLA nanofibers: p = 0.031, day 9; p = 0.030, day 22; PLLA/Col-I nanofibers: p = 0.004, day 22).
Figure 5

Influence of PLLA and PLLA/Col-I nanofibers on gene expression proteoglycanes. Time course of decorin (A) and biglycan (B) gene expression of TDF's cultured on PLLA and PLLA/Col-I nanofibers as compared to cover slips control.

Influence of PLLA and PLLA/Col-I nanofibers on genes associated with the integrin signalling pathway

Because elevated expression of integrins has been associated with healing tendons [27] and ligaments [28] it is likely that this signalling pathway is involved in the effects elicited by nanofiber scaffolds - especially when blended with collagen. Indeed, when cultured on these nanofiber scaffolds we found an increased expression of FAK, PYK and phosphoinositide 3-kinase (PI3K) gene (figure 6) compared to PLLA scaffolds or cover slip control. However we found no significance due to a broad inter-patient variability.
Figure 6

Influence of PLLA and PLLA/Col-I nanofibers on gene expression genes involved in integrin signalling. Gene expression of FAK, PYK and PI3K after 4 days of incubation PLLA and PLLA/Col-I as compared to cover slip control.

Discussion

PLLA is a biocompatible, biodegradable and by the Food and Drug Administration approved polymer [29, 30]. In bone reconstructive surgery it is commonly used in pins, screws or membranes [3134]. With respect to tendon repair, Koh et al. used PLLA patches to repair infraspinatus tears in a sheep model with good results [35]. When electrospun to nanofibers, these scaffolds were stable over a period of 30 days in aqueous solutions [25, 36] or in the presence of cells - although there was some loss in maximum load and strain [36].

Furthermore, several cell types like neural stem cells (NSCs) [37, 38], osteoblast like cell lines [3941], endothelial cells [42] or mesenchymal stem cells [36] can be cultured on PLLA nanofibers.

In this study we first examined the ability of TDF's to grow on PLLA nanofiber scaffolds. Compared to glass surfaces, a significantly reduced number of cells were found. One reason might be that the high hydrophobic surfaces of PLLA nanofibers prevent the cell attachment. However, gene expression of CCND at this time point decreased indicating that PLLA nanofibers influence the proliferation of TDF's. This suggestion is supported by earlier studies using hMSC, where a decrease in monoclonal antibody Ki67 positive cells was detected compared to glass surfaces [43, 44].

This inhibitory effect of PLLA polymer [45, 46] and PLLA nanofibers [12] on cell densities was equalized when PLLA was blended with collagen or gelatine. As described for hMSC [22, 47] we found no differences in cell densities of TDF's. This finding was accompanied by a normalisation of CCND expression. If so, this might indicate that the collagen component equalized the negative effects of PLLA on proliferation.

With respect to tendon replacement, besides growth, the formation of an extra cellular matrix plays an important role. Therefore, an ideal scaffold should support the formation of collagen I, the main component of the tendon, which is responsible for tensile strength [37, 48, 49]. When TDF's were cultured on PLLA/Col-I nanofibers, gene expression as well as the deposition of collagen I increased while the use of PLLA nanofibers alone had no or only minimal effect. These findings support earlier studies showing that PLLA/Col-I blend nanofibers increase the collagen expression in hMSC [22].

However, it is notable that the PLLA nanofibers influence the pattern of collagen deposition. The reason for this is unclear but it can be speculated that there is a link to the integrin pathway as seen in the expression of integrin in osteoblasts or stem cells on different nanofibers [50].

Within this context, the collagen integrin signalling may play an important role. Although not significant is that - due to broad inter-patient variability-TDF's expressed FAK, PYK and PI3K in higher levels when cultured on PLLA/Col-I blend nanofibers compared to PLLA nanofibers or glass surfaces. However, a part of this effect could be imputed to the nano-structured scaffold itself. In TDF's [51] as well as in other cell types, like osteoblasts [27], this effect was linked to increased α 2 and β 1 as well as α v and β 3 integrins and an up regulation of phospho-paxillin and phospho-FAK in cell lysates compared to solid surfaces.

However, besides collagen I, other components of the extra cellular matrix are important for a proper tendon repair. With respect to scar formation, the collagens III and X have been reported to play an important role [52]. Especially collagen III is expressed in higher amounts during tendon healing. This has implications for the stability of repaired tendons [53, 54]. Taking this for granted, the PLLA/Col-I blend nanofibers have to be seen critically due to their prolonged increase in collagen III expression. Here, further studies are needed in order to clarify whether this effect is compensated by the collagen I production.

As well as these aspects, tendon formation depends on the presence of proteoglycanes [55, 56] which are involved in the formation of collagen fibrils, especially in the fibril diameter [49]. The different deposition pattern of collagen observed on nanofiber scaffolds might be associated with a down regulation of biglycan and may result in weaker tendons. However, the interaction between collagen I and biglycan is not yet completely understood [57]. Therefore further studies were needed in order to elucidate the interaction of nanofiber scaffolds and matrix formation.

Conclusion

Taken together, this study indicates that the use of nanofibers influences the gene expression of genes associated with the extra cellular matrix formation. Here, the composition of the nanofiber plays a critical role. While PLLA/Col-I blend nanofibers enhance the collagen I and III formation, their expression on PLLA nanofibers was more comparable to controls. However, irrespective of the chemical composition of the fibres, the collagen deposition was altered, an effect which might be associated with a decreased expression of biglycanes.

Conflict of interests

The authors declare that they have no competing interests.

Declarations

Acknowledgements

We would like to thank A. Greiner, J.H. Wendorff and his study group for their support.

Authors’ Affiliations

(1)
Department of Orthopaedics and Rheumatology, University of Marburg

References

  1. Clark JM, Harryman DT: Tendons, ligaments, and capsule of the rotator cuff. Gross and microscopic anatomy. J Bone Joint Surg Am 1992, 74: 713–725.Google Scholar
  2. Ellman H: Diagnosis and treatment of incomplete rotator cuff tears. Clin Orthop Relat Res 1990, 64–74.Google Scholar
  3. Yamamoto A, Takagishi K, Osawa T, Yanagawa T, Nakajima D, Shitara H, Kobayashi T: Prevalence and risk factors of a rotator cuff tear in the general population. J Shoulder Elbow Surg 2010, 19(1):116–20. 10.1016/j.jse.2009.04.006View ArticleGoogle Scholar
  4. Moosmayer S, Smith HJ, Tariq R, Larmo A: Prevalence and characteristics of asymptomatic tears of the rotator cuff: an ultrasonographic and clinical study. J Bone Joint Surg Br 2009, 91: 196–200. 10.1302/0301-620X.91B2.21069View ArticleGoogle Scholar
  5. Hawkins RJ, Morin WD, Bonutti PM: Surgical treatment of full-thickness rotator cuff tears in patients 40 years of age or younger. J Shoulder Elbow Surg 1999, 8: 259–265. 10.1016/S1058-2746(99)90139-8View ArticleGoogle Scholar
  6. Codman EA: Rupture of the supraspinatus tendon. 1911. Clin Orthop Relat Res 1990, 3–26.Google Scholar
  7. Lee E, Bishop JY, Braman JP, Langford J, Gelber J, Flatow EL: Outcomes after arthroscopic rotator cuff repairs. J Shoulder Elbow Surg 2007, 16: 1–5. 10.1016/j.jse.2006.04.007View ArticleGoogle Scholar
  8. Gartsman GM, Khan M, Hammerman SM: Arthroscopic repair of full-thickness tears of the rotator cuff. J Bone Joint Surg Am 1998, 80: 832–840.Google Scholar
  9. Yamaguchi K, Ball CM, Galatz LM: Arthroscopic rotator cuff repair: transition from mini-open to all-arthroscopic. Clin Orthop Relat Res 2001, 83–94. 10.1097/00003086-200109000-00011Google Scholar
  10. Kovacevic D, Rodeo SA: Biological augmentation of rotator cuff tendon repair. Clin Orthop Relat Res 2008, 466: 622–633. 10.1007/s11999-007-0112-4View ArticleGoogle Scholar
  11. Frank CB, Hart DA, Shrive NG: Molecular biology and biomechanics of normal and healing ligaments--a review. Osteoarthritis Cartilage 1999, 7: 130–140. 10.1053/joca.1998.0168View ArticleGoogle Scholar
  12. Chuen FS, Chuk CY, Ping WY, Nar WW, Kim HL, Ming CK: Immunohistochemical characterization of cells in adult human patellar tendons. J Histochem Cytochem 2004, 52: 1151–1157. 10.1369/jhc.3A6232.2004View ArticleGoogle Scholar
  13. Tozer S, Duprez D: Tendon and ligament: development, repair and disease. Birth Defects Res C Embryo Today 2005, 75: 226–236. 10.1002/bdrc.20049View ArticleGoogle Scholar
  14. Derwin KA, Baker AR, Spragg RK, Leigh DR, Iannotti JP: Commercial extracellular matrix scaffolds for rotator cuff tendon repair. Biomechanical, biochemical, and cellular properties. J Bone Joint Surg Am 2006, 88: 2665–2672. 10.2106/JBJS.E.01307View ArticleGoogle Scholar
  15. Iannotti JP, Codsi MJ, Kwon YW, Derwin K, Ciccone J, Brems JJ: Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears. A randomized, controlled trial. J Bone Joint Surg Am 2006, 88: 1238–1244. 10.2106/JBJS.E.00524View ArticleGoogle Scholar
  16. Sclamberg SG, Tibone JE, Itamura JM, Kasraeian S: Six-month magnetic resonance imaging follow-up of large and massive rotator cuff repairs reinforced with porcine small intestinal submucosa. J Shoulder Elbow Surg 2004, 13: 538–541. 10.1016/j.jse.2004.03.005View ArticleGoogle Scholar
  17. Badylak SF: The extracellular matrix as a scaffold for tissue reconstruction. Semin Cell Dev Biol 2002, 13: 377–383. 10.1016/S1084952102000940View ArticleGoogle Scholar
  18. Gulotta LV, Rodeo SA: Growth factors for rotator cuff repair. Clin Sports Med 2009, 28: 13–23. 10.1016/j.csm.2008.09.002View ArticleGoogle Scholar
  19. Rodeo SA, Potter HG, Kawamura S, Turner AS, Kim HJ, Atkinson BL: Biologic augmentation of rotator cuff tendon-healing with use of a mixture of osteoinductive growth factors. J Bone Joint Surg Am 2007, 89: 2485–2497. 10.2106/JBJS.C.01627View ArticleGoogle Scholar
  20. Seeherman HJ, Archambault JM, Rodeo SA, Turner AS, Zekas L, D'Augusta D, Li XJ, Smith E, Wozney JM: rhBMP-12 accelerates healing of rotator cuff repairs in a sheep model. J Bone Joint Surg Am 2008, 90: 2206–2219. 10.2106/JBJS.G.00742View ArticleGoogle Scholar
  21. Schofer MD, Boudriot U, Bockelmann S, Walz A, Wendorff JH, Greiner A, Paletta JR, Fuchs-Winkelmann S: Effect of direct RGD incorporation in PLLA nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. J Mater Sci Mater Med 2009, 20: 1535–1540. 10.1007/s10856-009-3719-zView ArticleGoogle Scholar
  22. Schofer MD, Boudriot U, Leifeld I, Sutterlin RI, Rudisile M, Wendorff JH, Greiner A, Paletta JR, Fuchs-Winkelmann S: Characterization of a PLLA-collagen I blend nanofiber scaffold with respect to growth and osteogenic differentiation of human mesenchymal stem cells. ScientificWorldJournal 2009, 9: 118–129. 10.1100/tsw.2009.13View ArticleGoogle Scholar
  23. Kumbar SG, James R, Nukavarapu SP, Laurencin CT: Electrospun nanofiber scaffolds: engineering soft tissues. Biomed Mater 2008, 3: 034002. 10.1088/1748-6041/3/3/034002View ArticleGoogle Scholar
  24. Greiner A, Wendorff JH: Electrospinning: A fascinating method for the preparation of ultrathin fibres. Angewandte Chemie International Edition 2007, 46: 5670–5703. 10.1002/anie.200604646View ArticleGoogle Scholar
  25. Liao S, Li B, Ma Z, Wei H, Chan C, Ramakrishna S: Biomimetic electrospun nanofibers for tissue regeneration. J Biomedical Materials 2006, 1: R45–53. 10.1088/1748-6041/1/3/R01View ArticleGoogle Scholar
  26. Molloy TJ, de Bock CE, Wang Y, Murrell GA: Gene expression changes in SNAP-stimulated and iNOS-transfected tenocytes--expression of extracellular matrix genes and its implications for tendon-healing. J Orthop Res 2006, 24: 1869–1882. 10.1002/jor.20237View ArticleGoogle Scholar
  27. Harwood FL, Monosov AZ, Goomer RS, Gelberman RH, Winters SC, Silva MJ, Amiel D: Integrin expression is upregulated during early healing in a canine intrasynovial flexor tendon repair and controlled passive motion model. Connect Tissue Res 1998, 39: 309–316. 10.3109/03008209809021505View ArticleGoogle Scholar
  28. Schreck PJ, Kitabayashi LR, Amiel D, Akeson WH, Woods VL Jr: Integrin display increases in the wounded rabbit medial collateral ligament but not the wounded anterior cruciate ligament. J Orthop Res 1995, 13: 174–183. 10.1002/jor.1100130205View ArticleGoogle Scholar
  29. Suuronen R, Pohjonen T, Hietanen J, Lindqvist C: A five-year in vitro and in vivo study of the biodegradation of polylactide plates. J Oral Maxillofac Surg 1998, 56: 604–614. 10.1016/S0278-2391(98)90461-XView ArticleGoogle Scholar
  30. Suuronen R, Haers PE, Lindqvist C, Sailer HF: Update on Bioresorbable Plates in Maxillofacial Surgery. Facial Plastic Surgery 1999, 61–72. 10.1055/s-2008-1064301Google Scholar
  31. Waris E, Ashammakhi N, Kaarela O, Raatikainen T, Vasenius J: Use of bioabsorbable osteofixation devices in the hand. Journal of Hand Surgery - British Volume 2004, 29: 590–598. 10.1016/j.jhsb.2004.02.005View ArticleGoogle Scholar
  32. Suuronen R, Kallela I, Lindqvist C: Bioabsorbable plates and screws: Current state of the art in facial fracture repair. Journal of Cranio-Maxillofacial Trauma 2000, 6: 19–27.Google Scholar
  33. Tanaka N, Hirose K, Sakahashi H, Ishima T, Ishii S: Usefulness of bioabsorbable thread pins after resection arthroplasty for rheumatoid forefoot reconstruction. Foot & Ankle International 2004, 25: 496–502.Google Scholar
  34. Giavaresi G, Tschon M, Borsari V, Daly JH, Liggat JJ, Fini M, Bonazzi V, Nicolini A, Carpi A, Morra M, Cassinelli C, Giardino R: New polymers for drug delivery systems in orthopaedics: in vivo biocompatibility evaluation. Biomedicine & Pharmacotherapy 2004, 58: 411–417.View ArticleGoogle Scholar
  35. Koh JL, Szomor Z, Murrell GA, Warren RF: Supplementation of rotator cuff repair with a bioresorbable scaffold. Am J Sports Med 2002, 30: 410–413.Google Scholar
  36. Schofer MD, Boudriot U, Wack C, Leifeld I, Grabedunkel C, Dersch R, Rudisile M, Wendorff JH, Greiner A, Paletta JR, Fuchs-Winkelmann S: Influence of nanofibers on the growth and osteogenic differentiation of stem cells: a comparison of biological collagen nanofibers and synthetic PLLA fibers. J Mater Sci Mater Med 2009, 20: 767–774. 10.1007/s10856-008-3634-8View ArticleGoogle Scholar
  37. Yang PJ, Temenoff JS: Engineering orthopedic tissue interfaces. Tissue Eng Part B Rev 2009, 15: 127–141. 10.1089/ten.teb.2008.0371View ArticleGoogle Scholar
  38. Corey JM, Gertz CC, Wang BS, Birrell LK, Johnson SL, Martin DC, Feldman EL: The design of electrospun PLLA nanofiber scaffolds compatible with serum-free growth of primary motor and sensory neurons. Acta Biomaterialia 2008, 4: 863–875. 10.1016/j.actbio.2008.02.020View ArticleGoogle Scholar
  39. Boudriot U, Dersch R, Greiner A, Wendorff JH: Electrospinning approaches toward scaffold engineering--a brief overview. Artificial Organs 2006, 30: 785–792. 10.1111/j.1525-1594.2006.00301.xView ArticleGoogle Scholar
  40. Boudriot U, Goetz B, Dersch R, Greiner A, Wendorff HJ: Role of Electrospun Nanofibers in Stem Cell Technologies and Tissue Engineering. Macromolecular Symposia 2005, 225: 9–16. 10.1002/masy.200550702View ArticleGoogle Scholar
  41. Prabhakaran MP, Venugopal J, Ramakrishna S: Electrospun nanostructured scaffolds for bone tissue engineering. Acta Biomater 2009, 5: 2884–2893. 10.1016/j.actbio.2009.05.007View ArticleGoogle Scholar
  42. Lu H, Feng Z, Gu Z, Liu C: Growth of outgrowth endothelial cells on aligned PLLA nanofibrous scaffolds. J Mater Sci Mater Med 2009, 20: 1937–1944. 10.1007/s10856-009-3744-yView ArticleGoogle Scholar
  43. Schofer MD, Fuchs-Winkelmann S, Gräbedünkel C, Wack C, Dersch R, Rudisile M, Wendorff JH, Greiner A, Paletta JRJ, Boudriot U: Influence of Poly(L-Lactic Acid) Nanofibers and BMP-2-Containing Poly(L-Lactic Acid) Nanofibers on Growth and Osteogenic Differentiation of Human Mesenchymal Stem Cells. Thescientificworldjournal 2008, 8: 1269–1279. 10.1100/tsw.2008.163View ArticleGoogle Scholar
  44. Badami AS, Kreke MR, Thompson MS, Riffle JS, Goldstein AS: Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials 2006, 27: 596–606. 10.1016/j.biomaterials.2005.05.084View ArticleGoogle Scholar
  45. Jahno VD, Ribeiro GB, dos Santos LA, Ligabue R, Einloft S, Ferreira MR, Bombonato-Prado KF: Chemical synthesis and in vitro biocompatibility tests of poly (L-lactic acid). Journal of Biomedical Materials Research Part A 2007, 83: 209–215. 10.1002/jbm.a.31210View ArticleGoogle Scholar
  46. Ishaug SL, Yaszemski MJ, Bizios R, Mikos AG: Osteoblast function on synthetic biodegradable polymers. Journal of Biomedical Materials Research 1994, 28: 1445–1453. 10.1002/jbm.820281210View ArticleGoogle Scholar
  47. Kim HW, Yu HS, Lee HH: Nanofibrous matrices of poly(lactic acid) and gelatin polymeric blends for the improvement of cellular responses. Journal of Biomedical Materials Research Part A 2008, 87A: 25–32. 10.1002/jbm.a.31677View ArticleGoogle Scholar
  48. Doroski DM, Brink KS, Temenoff JS: Techniques for biological characterization of tissue-engineered tendon and ligament. Biomaterials 2007, 28: 187–202. 10.1016/j.biomaterials.2006.08.040View ArticleGoogle Scholar
  49. Riley GP, Harrall RL, Constant CR, Chard MD, Cawston TE, Hazleman BL: Tendon degeneration and chronic shoulder pain: changes in the collagen composition of the human rotator cuff tendons in rotator cuff tendinitis. Ann Rheum Dis 1994, 53: 359–366. 10.1136/ard.53.6.359View ArticleGoogle Scholar
  50. Liu S, Calderwood DA, Ginsberg MH: Integrin cytoplasmic domain-binding proteins. J Cell Sci 2000, 113(Pt 20):3563–3571.Google Scholar
  51. Moffat KL, Kwei AS, Spalazzi JP, Doty SB, Levine WN, Lu HH: Novel nanofiber-based scaffold for rotator cuff repair and augmentation. Tissue Eng Part A 2009, 15: 115–126. 10.1089/ten.tea.2008.0014View ArticleGoogle Scholar
  52. Brink HE, Bernstein J, Nicoll SB: Fetal dermal fibroblasts exhibit enhanced growth and collagen production in two- and three-dimensional culture in comparison to adult fibroblasts. J Tissue Eng Regen Med 2009, 3: 623–633. 10.1002/term.204View ArticleGoogle Scholar
  53. Pajala A, Melkko J, Leppilahti J, Ohtonen P, Soini Y, Risteli J: Tenascin-C and type I and III collagen expression in total Achilles tendon rupture. An immunohistochemical study. Histol Histopathol 2009, 24: 1207–1211.Google Scholar
  54. Riley G: The pathogenesis of tendinopathy. A molecular perspective. Rheumatology (Oxford) 2004, 43: 131–142. 10.1093/rheumatology/keg448View ArticleGoogle Scholar
  55. Franchi M, Trire A, Quaranta M, Orsini E, Ottani V: Collagen structure of tendon relates to function. ScientificWorldJournal 2007, 7: 404–420. 10.1100/tsw.2007.92View ArticleGoogle Scholar
  56. Fessel G, Snedeker JG: Evidence against proteoglycan mediated collagen fibril load transmission and dynamic viscoelasticity in tendon. Matrix Biol 2009, 28: 503–510. 10.1016/j.matbio.2009.08.002View ArticleGoogle Scholar
  57. Yoon JH, Halper J: Tendon proteoglycans: biochemistry and function. J Musculoskelet Neuronal Interact 2005, 5: 22–34.Google Scholar

Copyright

© Theisen et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.